Clinical trial
Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure…
NCT00417326 · Ono Pharmaceutical Co. Ltd, Industry · Completed
Key facts
| NCT number | NCT00417326 |
|---|---|
| Title | Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia |
| Official title | ONO-5046Na Phase II Study - A Pilot Study for Patients With Acute Respiratory Failure |
| Lead sponsor | Ono Pharmaceutical Co. Ltd, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Community-acquired Pneumonia |
| Intervention type | Drug |
| Interventions | ONO-5046Na |
| Enrollment | 174 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2009 |
| First posted | Jan 1, 2007 |
| Last update posted | Jun 13, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: